Avenue Therapeutics Inc. (NASDAQ: ATXI)
$1.9500
-0.0600 ( -2.50% ) 0.0K
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.
Market Data
Open
$1.9500
Previous close
$2.0100
Volume
0.0K
Market cap
$3.84M
Day range
$1.9310 - $2.0000
52 week range
$1.6000 - $26.4675
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | Feb 23, 2024 |
| def | Proxies and info statements | 2 | Jan 29, 2024 |
| pre | Proxies and info statements | 2 | Jan 17, 2024 |
| 8-k | 8K-related | 12 | Jan 12, 2024 |
| 8-k | 8K-related | 18 | Jan 08, 2024 |
| 4 | Insider transactions | 1 | Jan 03, 2024 |
| 4 | Insider transactions | 1 | Dec 13, 2023 |
| 3 | Insider transactions | 2 | Nov 28, 2023 |
| 8-k | 8K-related | 12 | Nov 24, 2023 |
| 8-k | 8K-related | 15 | Nov 13, 2023 |